Effect of Rebamipide Combined with Bifidobacterium Triple Viable in the Adjuvant Treatment of Hp-related Duodenal Ulcer and Its Influence on Serum IgA and IgG Levels

LI Zhongming; YI Chaofang

doi:10.14033/j.cnki.cfmr.2021.18.010

Home>Articles>Effect of Rebamipide Combined with Bifidobacterium Triple Viable in the Adjuvant Treatment of Hp-related Duodenal Ulcer and Its Influence on Serum IgA and IgG Levels

DOI: 10.14033/j.cnki.cfmr.2021.18.010

Effect of Rebamipide Combined with Bifidobacterium Triple Viable in the Adjuvant Treatment of Hp-related Duodenal Ulcer and Its Influence on Serum IgA and IgG Levels

LI Zhongming

YI Chaofang

Machine-generated Keywords：

Publication Date：2021-06-25

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：3( 27-29 )

Chinese and Foreign Medical Research

ISSN：1674-6805

Year, Vol.(Issue)：2021,19(18)